Events

A presentation on current activities, collaborations, and performance of the Prescription Medicine Authorisation Branch.

Post Market Surveillance - Considerations for medial device sponsors.

The increasing availability of Real World Evidence presents opportunities to improve treatments and repurpose medicines.

Updates on regulatory framework and key activities from the TGA's Medical Devices Authorisation Branch.

Updates on regulatory pathways for gene therapy products in Australia.

Updates on key activities for the TGA's Manufacturing Quality Branch.

Updates on current activities and focus areas for the Complementary and Over the Counter Medicines Branch.

Lessons learnt from COVID-19 to improve future vaccine development.

Current progress in establishing the Australian Unique Device Identification (UDI) System.

Current considerations for regulating the design and development of software based medical devices.

Patient-Matched Medical Devices (PMMDs) - key regulatory considerations.

A presentation discussing the lessons learnt from the Actemra (tocilizumab) shortage.

TGA speaker opportunity at ARCS conference.

Advisory Committee on Vaccines (ACV) meeting

Using UDIs in healthcare - real world experience.

Presentation on medical device regulations.

A webinar to provide an overview on the new Good Clinical Practice (GCP) Inspection Program guidance document.

UDI Webinar No. 8

Advisory Committee on Medical Devices (ACMD) meeting

Information on the new requirements for medicinal cannabis products in Australia.

Advisory Committee on Medicines (ACM) meeting

The 4th meeting of the Australian Dental Sector Working Group (DSWG), March 2022.

Guidance material about exporting therapeutic goods from Australia that aligns with current legislation, policy and business operations.

TGA presentation slides from eMedication Management Conference, Sydney (29-30 March 2022).

Webinar presentation : updated evidence guidelines for listed medicines